Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the refractive outcomes and optimize the clinical features of a new intraocular lens intended to treat the senile cataract.


Clinical Trial Description

InfiniteVision Optics has developed a new IOL system, the Precisight IOL. This IOL consists of a combination of two lenses: a base lens which is placed permanently into the capsular bag, and a front lens which sits on top of the base lens outside the capsular bag. The major advantage of this system is the adjustability of the primary IOL implantation which is done by front lens exchange. In case of either postoperative refractive adjustments or patient dissatisfaction with the visual performance, the front lens can be easily exchange by a less invasive surgery, avoiding a total IOL explantation. The implantation of the Precisight IOL is similar to the implantation of a traditional intraocular lens with no expected additional risk.

For all new IOLs, the IOL-constants are determined and provided by the manufacturer. They are calculated on the basis of eye models and clinical testing. In this study the biometric data of each patient's eye will be documented together with the implanted lens power and the postoperative stable refraction for calculation of the optimized IOL-constants.

In the present study, 125 subjects will be enrolled. Patients with a deviation from target refraction of more than 0.5 D spherical equivalent at the 2-3 month follow-up visit will undergo a secondary intervention for exchange of the front lens. These patients will be followed up for 1 year after front lens exchange.

Subjects will be screened during a pre-operative visit. Before the surgery visit, the subjected must have signed the Informed Consent Form.

After the surgery, patients will be followed up for one year. The visits will be scheduled at 1 day, 7-14 days, 2-3 months and 5-7 months and 1 year after surgery. Patients who underwent a surgery to exchange the front lens will be also followed up 1 day, 7-14 days, 2-3 months and 5-7 months and 1 year after the exchange surgery.

Investigator site staff will document the data in electronic Case Report Forms (eCRF). The data will be pseudonymized, i.e. only the year of birth and a code will be entered in the eCRF. Adverse events will be recorded in an eCRFs. Unexpected and serious adverse events are to be reported to the manufacturer.

Data cleaning will be done one month after last patient out and study report finished three months after last patient out. Subjects must be withdrawn from the study (i) at their own request, (ii) in case of intraoperative complication impacting the safety of the patient or (iii) in case of any postoperative complication if the continuation of the study has an impact on the safety of the patient. The study may terminate before completion if a high relative number of individual subject withdrawals due to the patient's requests and/or clinically relevant complications are observed. The IRB will be informed in due course accordingly.

The findings of this study will be published by the investigators in a scientific journal and presented at scientific meetings. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02970487
Study type Interventional
Source InfiniteVision Optics
Contact
Status Active, not recruiting
Phase N/A
Start date June 2016
Completion date July 2020

See also
  Status Clinical Trial Phase
Completed NCT04998409 - Evaluation of a Spherical Hydrophilic Acrylic Intraocular Lens
Completed NCT04252716 - VISPER: Randomised Comparison of Two OVDs in Cataract Surgery
Recruiting NCT05110222 - Cataract Lens Hardness Based on Phaco Tip Resistance
Recruiting NCT04266847 - Prospective Clinical Study of Preoperative and Postoperative Unilateral Mild Cataract Patients N/A
Recruiting NCT04175951 - Tecnis Eyhance Versus Rayner RayOne Study N/A
Recruiting NCT04572334 - Eyhance Autorefraction Study N/A
Completed NCT04140383 - Cataract Surgery In Patients With Advanced Age
Active, not recruiting NCT04570579 - Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement
Completed NCT05347615 - Achieving Hybrid Monovision By Paring Monofocal And EDOF Lens Technology
Completed NCT05129566 - Evaluation of Axial Stability of Two Models of Intraocular Lenses in Patients With an Eye Length More Than 26 mm N/A
Recruiting NCT05148507 - Optimization of the Ocular Surface Prior to Cataract Surgery Using PROKERA N/A
Completed NCT04655274 - Comparision of Visual Outcomes and Patient Satisfaction Between Two Diffractive Trifocal Intraocular Lenses
Completed NCT04255706 - Repeatability in Measurements of Two ssOCT and One OLCR Biometer N/A
Completed NCT05287269 - Ocular Coherence Tomography During Cataract Assessment
Completed NCT04545671 - Evaluation of a Trifocal Lens
Completed NCT04580550 - Axial Length Variability N/A
Recruiting NCT04265846 - Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia
Not yet recruiting NCT06429527 - Vision Test App and Questionnaire for 1-Week Post-Cataract Surgery Follow-Up: A Multi-Center Randomized Controlled Trial N/A
Completed NCT03970525 - Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery
Completed NCT04333056 - Comparison Between Two Ss-OCT Biometry